×

Valeant's price hikes are not new: Analyst

6:13 PM ET Tue, 29 Sept 2015

David Amsellem, senior research analyst at Piper Jaffray, discusses news that U.S. Democratic lawmakers denounced Valeant Pharmaceuticals for increasing the prices of two heart drugs.